CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 449957-450198 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T93041","span":{"begin":0,"end":241},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Using ELISA, we investigated the prevalence and levels of anti-GAD antibodies in patients with gluten ataxia (the most common neurological manifestation of gluten sensitivity) and patients with coeliac disease only in comparison to controls."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T172","span":{"begin":0,"end":241},"obj":"Sentence"}],"text":"Using ELISA, we investigated the prevalence and levels of anti-GAD antibodies in patients with gluten ataxia (the most common neurological manifestation of gluten sensitivity) and patients with coeliac disease only in comparison to controls."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T910","span":{"begin":102,"end":108},"obj":"Phenotype"},{"id":"T911","span":{"begin":156,"end":174},"obj":"Phenotype"}],"attributes":[{"id":"A910","pred":"hp_id","subj":"T910","obj":"http://purl.obolibrary.org/obo/HP_0001251"},{"id":"A911","pred":"hp_id","subj":"T911","obj":"http://purl.obolibrary.org/obo/HP_0012538"}],"text":"Using ELISA, we investigated the prevalence and levels of anti-GAD antibodies in patients with gluten ataxia (the most common neurological manifestation of gluten sensitivity) and patients with coeliac disease only in comparison to controls."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3070","span":{"begin":63,"end":66},"obj":"Disease"},{"id":"T3071","span":{"begin":102,"end":108},"obj":"Disease"},{"id":"T3072","span":{"begin":194,"end":209},"obj":"Disease"},{"id":"T51111","span":{"begin":63,"end":66},"obj":"Disease"},{"id":"T81188","span":{"begin":102,"end":108},"obj":"Disease"},{"id":"T31308","span":{"begin":194,"end":209},"obj":"Disease"}],"attributes":[{"id":"A3070","pred":"mondo_id","subj":"T3070","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"id":"A3071","pred":"mondo_id","subj":"T3071","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"},{"id":"A3072","pred":"mondo_id","subj":"T3072","obj":"http://purl.obolibrary.org/obo/MONDO_0005130"},{"id":"A8771","pred":"mondo_id","subj":"T51111","obj":"http://purl.obolibrary.org/obo/MONDO_0001942"},{"id":"A8003","pred":"mondo_id","subj":"T81188","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"},{"id":"A49054","pred":"mondo_id","subj":"T31308","obj":"http://purl.obolibrary.org/obo/MONDO_0005130"}],"text":"Using ELISA, we investigated the prevalence and levels of anti-GAD antibodies in patients with gluten ataxia (the most common neurological manifestation of gluten sensitivity) and patients with coeliac disease only in comparison to controls."}